BMO Eq Wght US HlthCare Hdgd to CAD ETF (ZUH.TO)

62.48 -0.37  -0.59% TSX Jun 4, 09:30 Delayed 15m CAD
View Full Chart
Price Chart

Key Stats

Net Asset Value 62.85
Discount or Premium to NAV 0.00%
Turnover Ratio 35.47%
1 Year Fund Level Flows -7.306M
View All ZUH.TO News

News

  • Wire
    Headline
    Time (ET)

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 8.47% 8.26% -- --
3M 10.48% 10.89% -- --
6M 7.37% 7.45% -- --
YTD 4.51% 4.47% -- --
1Y 24.57% 24.74% -- --
3Y 11.26% 11.24% -- --
5Y 7.74% 7.74% -- --
10Y 15.97% 16.00% -- --
15Y -- -- -- --
20Y -- -- -- --
As of June 3, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 2.15% 2.63% 0.48%
Stock 100.1% 100.1% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other -2.21% 0.00% 2.21%
As of April 30, 2020

Region Exposure

Americas 96.86%
North America 96.86%
Latin America 0.00%
Greater Europe 3.14%
United Kingdom 1.64%
Europe Developed 1.50%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of April 30, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of April 30, 2020

Stock Market Capitalization

Giant 19.32%
Large 43.93%
Medium 36.75%
Small 0.00%
Micro 0.00%
As of April 30, 2020

Stock Style Exposure

Large Cap Value 9.60%
Large Cap Blend 34.63%
Large Cap Growth 19.02%
Mid Cap Value 4.77%
Mid Cap Blend 11.39%
Mid Cap Growth 20.58%
Small Cap Value 0.00%
Small Cap Blend 0.00%
Small Cap Growth 0.00%
As of April 30, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
EXAS Exact Sciences Corp 2.11% 87.71 -1.82%
DXCM DexCom Inc 2.02% 354.12 -3.21%
ILMN Illumina Inc 2.02% 361.01 +0.75%
SGEN Seattle Genetics Inc 1.97% 154.64 -0.26%
ALXN Alexion Pharmaceuticals Inc 1.97% 113.23 -0.47%
INCY Incyte Corp 1.95% 98.78 -0.05%
ALNY Alnylam Pharmaceuticals Inc 1.91% 135.89 -0.99%
WST West Pharmaceutical Services Inc 1.91% 208.67 -0.33%
HOLX Hologic Inc 1.82% 53.43 -0.48%
PKI PerkinElmer Inc 1.81% 103.25 -0.59%
As of April 30, 2020
Advertisement

Basic Info

Investment Strategy
The BMO Equal Weight US Health Care Hedged to CAD Index ETF has been designed to replicate, to the extent possible, the performance of the Solactive Equal Weight US Health Care Index Canadian Dollar Hedged, net of expenses. The Fund invests in and holds the Constituent Securities of the Index in the same proportion as they are reflected in the Index. The US dollar exposure is hedged back to Canadian dollars.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Growth
Fixed Income Style --
Broad Asset Class --
Broad Category Equity
Category Name Sector Equity
Prospectus Objective --
Fund Owner Firm Name BMO Asset Management Inc
Benchmark Index
Solactive Equal Weight US HC Hdg TR CAD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Not Disclosed 9.96 yrs

Net Fund Flows

1M 18.19M
3M 36.16M
6M 36.16M
YTD 36.16M
1Y -7.306M
3Y 50.78M
5Y 8.658M
10Y 225.50M
As of May 31, 2020

Risk Info

Beta (5Y) 0.9009
Max Drawdown (All) 31.89%
Historical Sharpe Ratio (10Y) 1.036
Historical Sortino (All) 1.183
30-Day Rolling Volatility 19.89%
Daily Value at Risk (VaR) 1% (All) 3.18%
Monthly Value at Risk (VaR) 1% (All) 13.25%

Fundamentals

Dividend Yield TTM (6-4-20) 0.32%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 26.35
Weighted Average Price to Sales Ratio 2.654
Weighted Average Price to Book Ratio 3.933
Weighted Median ROE 19.52%
Weighted Median ROA 7.66%
Forecasted Dividend Yield 0.82%
Forecasted PE Ratio 20.03
Forecasted Price to Sales Ratio 2.452
Forecasted Price to Book Ratio 3.922
Number of Holdings 90
As of April 30, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 9.70%
Forecasted Book Value Growth 4.35%
Forecasted Cash Flow Growth 9.58%
Forecasted Earnings Growth 18.34%
Forecasted Revenue Growth 10.66%
As of April 30, 2020

Comparables

Edit

Attributes

Key Dates
Inception Date 5/19/2010
Termination Date
Last Annual Report Date 12/31/2019
Last Prospectus Date 2/7/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP Yes
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.